Case Studies

• Blenderized Tube Feeding in Metabolic Patients: Survey Results from Metabolic Dietitians in the U.S.

  Poster presented at GMDI 2024 which included questions about Real Food Blends. Topics covered include current practice with blenderized tube feeding (BTF), assessment of tolerability, benefits and challenges, and use of homemade versus commercial options.

• Posters from GMDI 2022

  Two posters presented at GMDI 2022 which were co-authored and supported by Nutricia North America or Nutricia Global Research.

  • Examining the self-described impact of COVID-19 on the lives and interactions of adults with PKU View Poster
  • Fecal microbiota composition and activity of patients with propionic acidemia View Poster
• A glycomacropeptide based protein substitute helps promote stable blood phenylalanine and branched chain amino acids in patients with phenylketonuria

  Poster presented at SIMD 2018 which included Nutricia’s PhenylAde GMP Drink Mix. Stable plasma amino acids over 28 days with significant improvement in plasma tyrosine levels and branched chain amino acids within recommended range in 12 individuals with PKU on PhenylAde GMP Drink Mix

• Posters from GMDI 2018

  Three posters presented at GMDI 2018 which included Nutricia products.

  • Greater satiety, stable blood phenylalanine and stable nutrient intake in patients with PKU taking a Glycomacropeptide-based protein substitute for 28 days View Poster
  • Dietary fibers and propionate production in an in vitro gut fermentation system View Poster
  • Lysine-Free, Arginine-Enriched Medical Foods for the Management of Glutaric Aciduria Type 1 View Poster
• Nutritional management of an adult with Phenylketonuria with the use of a Glycomacropeptide-based PKU formula

  This case report, provided by a UK clinician for Nutricia UK, reviews the successful introduction of PhenylAde GMP Drink Mix in an adult female with classical PKU.

• Nutrition management of an infant with GA-1 and transition to a tryptophan-reduced medical food

  This case report by Krista Viau, PhD, RDN, describes an infant who successfully transitioned from a tryptophan-free metabolic infant formula to tryptophan-low GA1 Early Years to increase plasma tryptophan levels without exceeding therapeutic range for plasma lysine.

• Transitioning: TYR infant formula to TYR Anamix Next: Seamless transition to a fiber-containing medical food

  This case report by Grace Stuhrman, MS, RD, LD, describes the seamless transition from a metabolic infant formula to a next stage metabolic follow-on formula in a patient with tyrosinemia.

• Transition to and Acceptance of TYR Anamix Next

  This case report by Manon Bouchard, RD, discusses the successful transition from a metabolic infant infant formula to a fiber-containing metabolic follow-on formula in a patient with tryrosinemia.

• PKU Infant Case Studies

  This case report, by Krista Viau, PhD, RDN, describes three infants with PKU who have been successfully started on, or transitioned onto, Nutricia's PKU Periflex® Early Years.

• Newly Diagnosed IVA Baby

  This case report, by Krista Viau, PhD, RDN, describes the start of a newly diagnosed IVA infant onto Nutricia's IVA Anamix® Early Years.

• Managing a Delayed PKU Diagnosis and T2 Diabetes

  This case report, by Jill Skrabal, MS, RD, LMNT, CDE, describes the medical and nutrition management of an adult male with PKU and T2 diabetes.

Return to top of the page